Selexipag denied for missing prior authorization by Humana?

Humana's specific coverage criteria for selexipag are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for Selexipag

Selexipag is a high-cost specialty medication for pulmonary arterial hypertension (PAH), and Humana — like most insurers — requires prior authorization (PA) before dispensing it. A denial at the PA stage typically means either that the PA was not submitted before dispensing, that the submitted documentation was incomplete, or that Humana's reviewer determined the clinical criteria in its medical policy were not met by the information provided.

## Why This Denial Is Appealable

A prior-authorization denial is not a final coverage decision. It is the beginning of a review process, and the appeal pathway exists specifically to allow your prescriber to supply additional clinical evidence that may not have been captured in the initial submission. Many PA denials are overturned on internal appeal when the right documentation is provided.

## Your Federal Appeal Rights

• Internal appeal: File promptly. Humana must provide a written denial with the specific criteria not met. Your appeal should directly address each unmet criterion with clinical documentation.
• ACA §2719 / External Review: If the internal appeal is denied, most commercial and marketplace plans must provide access to independent external review. You generally have approximately four months from the denial notice.
• ERISA §503 (employer plans): You are entitled to a full-and-fair review, access to the complete claim file, and a written explanation of the criteria applied.
• Expedited PA and appeal: If your prescriber certifies that standard review timelines would seriously jeopardize your health, request expedited PA reconsideration or expedited appeal — Humana must respond within hours for truly urgent cases.

## Appeal Timeline

1. Obtain the written PA denial and identify each specific criterion cited. 2. Work with your prescriber to compile documentation addressing every cited criterion. 3. File the internal appeal within the deadline stated in the denial letter. 4. If upheld, immediately request external review — do not let the four-month window lapse.

## Documentation to Gather

• Diagnosis confirmation: Right-heart catheterization report, echocardiography, and physician notes establishing PAH diagnosis and functional class.
• Prior therapy history: Dates, agents, and documented outcomes or reasons for discontinuation of all prior PAH-directed therapies.
• Current clinical status: Recent functional assessments (such as six-minute walk distance), laboratory markers, and any evidence of disease progression or instability.
• Prescriber medical-necessity letter: A detailed letter from the PAH specialist directly addressing each criterion in Humana's PA policy for selexipag, citing specific chart facts.
• Relevant guideline support: A reference to the applicable guideline organization's recommendations for PAH therapy (without quoting specific numbers) to contextualize the prescriber's clinical reasoning.

## Criteria-Mapping Structure

Request Humana's PA criteria document for selexipag (it must be provided upon request). Create a table with one row per criterion — column one states the criterion verbatim, column two cites the specific chart note, lab value, or test result that satisfies it. Submit this table as the centerpiece of your appeal letter.